Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment
- PMID: 18191574
- DOI: 10.1016/j.jocn.2007.02.002
Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment
Abstract
This study was performed to investigate the differences in response to botulinum toxin treatment between patients with idiopathic versus neurovascular hemifacial spasm. A total of 69 patients with hemifacial spasm were investigated prospectively with cranial magnetic resonance imaging and magnetic resonance angiography. Neurovascular contact was found in 23 patients. All patients were assessed with a severity scale and a disease awareness scale. After treatment, the patients with idiopathic hemifacial spasm improved significantly in terms of both severity and awareness scores, but the patients with neurovascular hemifacial spasm improved only in the awareness scores. In conclusion, patients with idiopathic hemifacial spasm experienced a greater improvement after treatment with botulinum toxin than did patients with neurovascular hemifacial spasm.
Similar articles
-
[Hemifacial spasm and its treatment with botulinum toxin].Tunis Med. 1999 Jan;77(1):41-4. Tunis Med. 1999. PMID: 10333697 Clinical Trial. French. No abstract available.
-
Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).J Neurol Sci. 2004 Apr 15;219(1-2):151-5. doi: 10.1016/j.jns.2004.01.010. J Neurol Sci. 2004. PMID: 15050451
-
Treatment outcome correlates with knowledge of disease in hemifacial spasm.Clin Neurol Neurosurg. 2008 Sep;110(8):813-7. doi: 10.1016/j.clineuro.2008.05.010. Epub 2008 Jun 25. Clin Neurol Neurosurg. 2008. PMID: 18583029
-
Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.J Neural Transm (Vienna). 2008;115(4):585-91. doi: 10.1007/s00702-007-0768-7. Epub 2007 Jun 11. J Neural Transm (Vienna). 2008. PMID: 17558461 Review.
-
Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.Eur J Neurol. 2006 Feb;13 Suppl 1:30-5. doi: 10.1111/j.1468-1331.2006.01442.x. Eur J Neurol. 2006. PMID: 16417595 Review.
Cited by
-
Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters.J Neural Transm (Vienna). 2021 Jun;128(6):793-802. doi: 10.1007/s00702-021-02343-x. Epub 2021 May 8. J Neural Transm (Vienna). 2021. PMID: 33963897 Free PMC article.
-
Interrater reliability of motor severity scales for hemifacial spasm.J Neural Transm (Vienna). 2023 Oct;130(10):1269-1279. doi: 10.1007/s00702-023-02667-w. Epub 2023 Jul 19. J Neural Transm (Vienna). 2023. PMID: 37466750 Free PMC article.
-
Validation of the Hemifacial Spasm Grading Scale: a clinical tool for hemifacial spasm.Neurol Sci. 2019 Sep;40(9):1887-1892. doi: 10.1007/s10072-019-03921-4. Epub 2019 May 10. Neurol Sci. 2019. PMID: 31076941
-
Efficacy and safety of botulinum neurotoxin in the treatment of hemifacial spasms: a systematic review and meta-analysis.BMC Neurol. 2024 Oct 29;24(1):420. doi: 10.1186/s12883-024-03883-x. BMC Neurol. 2024. PMID: 39472778 Free PMC article.
-
Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.Toxins (Basel). 2021 Dec 9;13(12):881. doi: 10.3390/toxins13120881. Toxins (Basel). 2021. PMID: 34941718 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources